HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.

Abstract
The inhibitory effects of a new boron compound, hydroxy salicylhydroxamato boron (III) (SHB) and ultrasound of frequency 25 KHz (US) on the growth of ascites tumor in female Swiss mice were studied by monitoring the survival and the tumor growth in the treated tumor bearing mice and also the transplantability and the DNA synthesis in the treated tumor (Ehrlich ascites carcinoma) cells. While SHB alone produced a highly significant antitumor activity, US alone produced a small but significant effect. The combination of SHB and US produced significantly greater antitumor activity than SHB alone. The mechanisms of SHB and US actionary are discussed.
AuthorsP Ghosh, P Sur, S P Bag, B Sur, S N Chatterjee
JournalNeoplasma (Neoplasma) Vol. 45 Issue 6 Pg. 384-8 ( 1998) ISSN: 0028-2685 [Print] Slovakia
PMID10210114 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Boron Compounds
  • hydroxysalicylhydroxamato boron(III)
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Boron Compounds (therapeutic use)
  • Carcinoma, Ehrlich Tumor (pathology, therapy)
  • Combined Modality Therapy
  • Female
  • Mice
  • Ultrasonic Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: